Two randomized phase III clinical trials evaluating anti-inflammatory dose doxycycline (40-mg doxycycline, USP capsules) administered once daily for treatment of rosacea
Top Cited Papers
Open Access
- 31 May 2007
- journal article
- research article
- Published by Elsevier BV in Journal of the American Academy of Dermatology
- Vol. 56 (5), 791-802
- https://doi.org/10.1016/j.jaad.2006.11.021
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Adherence to MedicationThe New England Journal of Medicine, 2005
- Could matrix metalloproteinase‐9 be a link between Demodex folliculorum and rosacea?Journal of the European Academy of Dermatology and Venereology, 2005
- Demodicosis and rosacea: Epidemiology and significance in daily dermatologic practiceJournal of the American Academy of Dermatology, 2005
- Rosacea: II. TherapyJournal of the American Academy of Dermatology, 2004
- Rosacea: I. Etiology, pathogenesis, and subtype classificationJournal of the American Academy of Dermatology, 2004
- Standard grading system for rosacea: report of the National Rosacea Society Expert Committee on the classification and staging of rosaceaJournal of the American Academy of Dermatology, 2004
- Temperature regulates bacterial protein production: possible role in rosaceaJournal of the American Academy of Dermatology, 2004
- Using MedDRADrug Safety, 2004
- The role of free oxygen radicals in the aetiopathogenesis of rosaceaClinical and Experimental Dermatology, 2003
- A clinical and histopathologic study of granulomatous rosaceaJournal of the American Academy of Dermatology, 1991